These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28566252)

  • 1. Stop measles in Switzerland - The importance of travel medicine.
    Bühler S; Lang P; Bally B; Hatz C; Jaeger VK
    Vaccine; 2017 Jun; 35(30):3760-3763. PubMed ID: 28566252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Travellers' profile, travel patterns and vaccine practices--a 10-year prospective study in a Swiss Travel Clinic.
    Boubaker R; Meige P; Mialet C; Buffat CN; Uwanyiligira M; Widmer F; Rochat J; Fossati AH; Souvannaraj-Blanchant M; Payot S; Rochat L; de Vallière S; Genton B; D'Acremont V
    J Travel Med; 2016 Jan; 23(1):. PubMed ID: 26792229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a measles vaccination campaign at the universities in the city of Zurich, 2019.
    Lang P; Zens KD; Bally B; Meier C; Martin B; Fehr J
    Public Health; 2021 Jun; 195():51-53. PubMed ID: 34052507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increase in measles vaccination coverage among young adults in Switzerland: a campaign or cohort effect?
    Altpeter E; Wymann MN; Richard JL; Mäusezahl-Feuz M
    Int J Public Health; 2018 Jun; 63(5):589-599. PubMed ID: 29675705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Switzerland eliminates measles. National Strategy for the Elimination of Measles 2011-2015].
    Koch D; Richard JL; Hanhart J; Eckert T; Eigenmann Schüttel S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1297-304. PubMed ID: 23990093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A profile of travelers--an analysis from a large swiss travel clinic.
    Bühler S; Rüegg R; Steffen R; Hatz C; Jaeger VK
    J Travel Med; 2014; 21(5):324-31. PubMed ID: 24934830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward measles elimination--Southern Africa, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):585-9. PubMed ID: 10428097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles in Europe: an epidemiological assessment.
    Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K;
    Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Travel medicine consultation: An opportunity to improve coverage for routine vaccinations.
    Aba YT; Gagneux-Brunon A; Andrillat C; Fouilloux P; Daoud F; Defontaine C; Lucht F; Botelho-Nevers E
    Med Mal Infect; 2019 Jun; 49(4):257-263. PubMed ID: 30583868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The elimination of measles in Iran.
    Namaki S; Gouya MM; Zahraei SM; Khalili N; Sobhani H; Akbari ME
    Lancet Glob Health; 2020 Feb; 8(2):e173-e174. PubMed ID: 31981549
    [No Abstract]   [Full Text] [Related]  

  • 12. Approaching measles elimination in Switzerland: changing epidemiology 2007-2018.
    Richard JL; Mäusezahl M; Basler S; Eckert N
    Swiss Med Wkly; 2019 Jun; 149():w20102. PubMed ID: 31185128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards measles elimination in Singapore.
    Ho HJ; Low C; Ang LW; Cutter JL; Tay J; Chan KP; Ooi PL; Thoon KC; Goh KT
    Vaccine; 2014 Dec; 32(51):6927-6933. PubMed ID: 25444818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large measles epidemic in Switzerland from 2006 to 2009: consequences for the elimination of measles in Europe.
    Richard JL; Masserey Spicher V
    Euro Surveill; 2009 Dec; 14(50):. PubMed ID: 20070934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles prevention.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Jul; 36(26):409-18, 423-5. PubMed ID: 3110568
    [No Abstract]   [Full Text] [Related]  

  • 17. Leads from the MMWR. Measles prevention.
    JAMA; 1987 Aug; 258(7):890-5. PubMed ID: 3613013
    [No Abstract]   [Full Text] [Related]  

  • 18. First 5 years of measles elimination in southern Africa: 1996-2000.
    Biellik R; Madema S; Taole A; Kutsulukuta A; Allies E; Eggers R; Ngcobo N; Nxumalo M; Shearley A; Mabuzane E; Kufa E; Okwo-Bele JM
    Lancet; 2002 May; 359(9317):1564-8. PubMed ID: 12047966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles in the 21st Century, a Continuing Preventable Risk to Travelers: Data From the GeoSentinel Global Network.
    Sotir MJ; Esposito DH; Barnett ED; Leder K; Kozarsky PE; Lim PL; Gkrania-Klotsas E; Hamer DH; Kuhn S; Connor BA; Pradhan R; Caumes E;
    Clin Infect Dis; 2016 Jan; 62(2):210-2. PubMed ID: 26400996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards measles elimination -South-East Asia Region, 2003-2013.
    Wkly Epidemiol Rec; 2015 Jun; 90(24):297-305. PubMed ID: 26072524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.